title,time_published,url,ticker,relevance_score,ticker_sentiment_label,ticker_sentiment_score
"Why Taysha Gene Therapies Shares Are Trading Higher By Around 27%; Here Are 20 Stocks Moving Premarket - BYND Cannasoft Enterprise  ( NASDAQ:BCAN ) , Aquestive Therapeutics  ( NASDAQ:AQST ) ",20240320T122039,https://www.benzinga.com/news/24/03/37844820/why-taysha-gene-therapies-shares-are-trading-higher-by-around-27-here-are-20-stocks-moving-premarket,CMND,0.185781,Somewhat-Bullish,0.310014
"Why BSQUARE Shares Are Trading Higher By Around 44%; Here Are 20 Stocks Moving Premarket - AgileThought  ( NASDAQ:AGIL ) , Agape ATP  ( NASDAQ:ATPC ) ",20231012T132934,https://www.benzinga.com/news/23/10/35217585/why-bsquare-shares-are-trading-higher-by-around-44-here-are-20-stocks-moving-premarket,CMND,0.166169,Somewhat-Bearish,-0.254502
"Why Bed Bath & Beyond Shares Are Trading Lower By 23%; Here Are 20 Stocks Moving Premarket - Bed Bath & Beyond  ( NASDAQ:BBBY ) , Apollomics  ( NASDAQ:APLM ) ",20230426T123739,https://www.benzinga.com/news/23/04/32009221/why-bed-bath-beyond-shares-are-trading-lower-by-23-here-are-20-stocks-moving-premarket,CMND,0.12645,Neutral,0.141574
Why Doximity Shares Are Trading Higher By Over 28%; Here Are 20 Stocks Moving Premarket - Doximity  ( NYSE:DOCS ) ,20240809T090452,https://www.benzinga.com/news/24/08/40277872/why-doximity-shares-are-trading-higher-by-over-28-here-are-20-stocks-moving-premarket,CMND,0.142565,Neutral,0.11776
Clearmind Medicine Granted Patent for Binge Behavior Treatment by the Macau International Intellectual Property Office,20250102T124500,https://www.globenewswire.com/news-release/2025/01/02/3003488/0/en/Clearmind-Medicine-Granted-Patent-for-Binge-Behavior-Treatment-by-the-Macau-International-Intellectual-Property-Office.html,CMND,0.14573,Somewhat-Bullish,0.174542
Clearmind Medicine Granted Patent for Binge Behavior Treatment by the Macau International Intellectual Property Office - Clearmind Medicine  ( NASDAQ:CMND ) ,20250102T124500,https://www.benzinga.com/pressreleases/25/01/g42762285/clearmind-medicine-granted-patent-for-binge-behavior-treatment-by-the-macau-international-intellec,CMND,0.139534,Somewhat-Bullish,0.162351
Clearmind Medicine Looks to Move Forward with its Novel Psychedelic MEAI- Based Alcohol Substitute,20241226T115900,https://www.globenewswire.com/news-release/2024/12/26/3001921/0/en/Clearmind-Medicine-Looks-to-Move-Forward-with-its-Novel-Psychedelic-MEAI-Based-Alcohol-Substitute.html,CMND,0.144059,Somewhat-Bullish,0.210427
"Why Is Penny Stock Clearmind Gaining Today? - AdvisorShares Psychedelics ETF  ( ARCA:PSIL ) , Clearmind Medicine  ( NASDAQ:CMND ) ",20241224T163251,https://www.benzinga.com/general/health-care/24/12/42672992/why-is-penny-stock-clearmind-gaining-today,CMND,0.84035,Bullish,0.369155
Clearmind Medicine Receives IRB Approval for its FDA-Regulated Clinical Trial,20241224T115500,https://www.globenewswire.com/news-release/2024/12/24/3001656/0/en/Clearmind-Medicine-Receives-IRB-Approval-for-its-FDA-Regulated-Clinical-Trial.html,CMND,0.418689,Neutral,0.074862
Clearmind Medicine and Dr Glitter Pty Ltd Sign Term Sheet for Mutual Development of Novel Psychedelic MEAI- Based Alcohol Substitute in ActivCrystal™ Format,20241216T133700,https://www.globenewswire.com/news-release/2024/12/16/2997541/0/en/Clearmind-Medicine-and-Dr-Glitter-Pty-Ltd-Sign-Term-Sheet-for-Mutual-Development-of-Novel-Psychedelic-MEAI-Based-Alcohol-Substitute-in-ActivCrystal-Format.html,CMND,0.135157,Somewhat-Bullish,0.202002
Clearmind Medicine and Dr Glitter Pty Ltd Sign Term Sheet for Mutual Development of Novel Psychedelic MEAI- Based Alcohol Substitute in ActivCrystal™ Format - Clearmind Medicine  ( NASDAQ:CMND ) ,20241216T133700,https://www.benzinga.com/pressreleases/24/12/g42507585/clearmind-medicine-and-dr-glitter-pty-ltd-sign-term-sheet-for-mutual-development-of-novel-psychede,CMND,0.131105,Somewhat-Bullish,0.195235
Why Aehr Test Systems Shares Are Trading Higher By Around 14%; Here Are 20 Stocks Moving Premarket - Aehr Test System  ( NASDAQ:AEHR ) ,20241011T102036,https://www.benzinga.com/news/24/10/41288032/why-aehr-test-systems-shares-are-trading-higher-by-around-14-here-are-20-stocks-moving-premarket,CMND,0.199037,Neutral,-0.020233
Clearmind Medicine Files International Patent For Ibogaine Combination Therapy - Clearmind Medicine  ( NASDAQ:CMND ) ,20240917T163105,https://www.benzinga.com/markets/cannabis/24/09/40904875/clearmind-medicine-files-international-patent-for-ibogaine-combination-therapy,CMND,0.339356,Bullish,0.401188
Why Intel Shares Are Trading Higher By Around 7%; Here Are 20 Stocks Moving Premarket - Ocean Power Techs  ( AMEX:OPTT ) ,20240917T094813,https://www.benzinga.com/news/24/09/40893104/why-intel-shares-are-trading-higher-by-around-7-here-are-20-stocks-moving-premarket,CMND,0.079392,Neutral,0.085288
SciSparc-Clearmind Medicine Collaboration Announces the Publication of an International Patent Application for Pioneering Ibogaine Combination Therapy,20240916T200600,https://www.globenewswire.com/news-release/2024/09/16/2947021/0/en/SciSparc-Clearmind-Medicine-Collaboration-Announces-the-Publication-of-an-International-Patent-Application-for-Pioneering-Ibogaine-Combination-Therapy.html,CMND,0.179343,Neutral,0.117249
Clearmind Medicine Announces the Notice of an International Patent Application for Pioneering Ibogaine Combination Therapy,20240916T200600,https://www.globenewswire.com/news-release/2024/09/16/2947020/0/en/Clearmind-Medicine-Announces-the-Notice-of-an-International-Patent-Application-for-Pioneering-Ibogaine-Combination-Therapy.html,CMND,0.16117,Somewhat-Bullish,0.168324
Clearmind Medicine and Yissum File International Patent Application for Revolutionary Psychedelic Compounds for PTSD Treatment,20240912T122000,https://www.globenewswire.com/news-release/2024/09/12/2945176/0/en/Clearmind-Medicine-and-Yissum-File-International-Patent-Application-for-Revolutionary-Psychedelic-Compounds-for-PTSD-Treatment.html,CMND,0.160633,Somewhat-Bullish,0.156306
SciSparc-Clearmind Medicine Collaboration Leads to Publication of International Patent Application for Innovative MDMA-Based Combination Treatment,20240906T115500,https://www.globenewswire.com/news-release/2024/09/06/2942115/0/en/SciSparc-Clearmind-Medicine-Collaboration-Leads-to-Publication-of-International-Patent-Application-for-Innovative-MDMA-Based-Combination-Treatment.html,CMND,0.208017,Neutral,0.129272
SciSparc-Clearmind Medicine Collaboration Leads to Publication of International Patent Application for Innovative MDMA-Based Combination Treatment - Clearmind Medicine  ( NASDAQ:CMND ) ,20240906T115500,https://www.benzinga.com/pressreleases/24/09/g40747684/scisparc-clearmind-medicine-collaboration-leads-to-publication-of-international-patent-application,CMND,0.199037,Neutral,0.120136
Clearmind Medicine Announces Publication of International Patent Application for Innovative MDMA-Based Combination Treatment,20240906T115500,https://www.globenewswire.com/news-release/2024/09/06/2942116/0/en/Clearmind-Medicine-Announces-Publication-of-International-Patent-Application-for-Innovative-MDMA-Based-Combination-Treatment.html,CMND,0.166169,Neutral,0.139342
Clearmind Medicine Announces Publication of International Patent Application for Innovative MDMA-Based Combination Treatment - Clearmind Medicine  ( NASDAQ:CMND ) ,20240906T115500,https://www.benzinga.com/pressreleases/24/09/g40747685/clearmind-medicine-announces-publication-of-international-patent-application-for-innovative-mdma-b,CMND,0.160365,Neutral,0.129142
SciSparc-Clearmind Medicine Collaboration Leads to Publication of Application for Innovative Ketamine-Based Combination,20240829T202500,https://www.globenewswire.com/news-release/2024/08/29/2938125/0/en/SciSparc-Clearmind-Medicine-Collaboration-Leads-to-Publication-of-Application-for-Innovative-Ketamine-Based-Combination.html,CMND,0.16099,Neutral,0.102571
Clearmind Medicine Announces Publication of its Patent Application for Innovative Ketamine-Based Combination Treatment,20240829T202500,https://www.globenewswire.com/news-release/2024/08/29/2938124/0/en/Clearmind-Medicine-Announces-Publication-of-its-Patent-Application-for-Innovative-Ketamine-Based-Combination-Treatment.html,CMND,0.11166,Neutral,0.115382
Clearmind Medicine Granted U.S. Patent Approval for Binge Behavior Treatment,20240821T201100,https://www.globenewswire.com/news-release/2024/08/21/2933847/0/en/Clearmind-Medicine-Granted-U-S-Patent-Approval-for-Binge-Behavior-Treatment.html,CMND,0.137148,Neutral,0.147045
Clearmind Medicine and Yissum Expand Collaboration with International Patent Application for Generation 3.0 Psychedelic Compounds to Treat Mental Disorders,20240816T201400,https://www.globenewswire.com/news-release/2024/08/16/2931717/0/en/Clearmind-Medicine-and-Yissum-Expand-Collaboration-with-International-Patent-Application-for-Generation-3-0-Psychedelic-Compounds-to-Treat-Mental-Disorders.html,CMND,0.126339,Neutral,0.110497
SciSparc's Collaboration with Clearmind Medicine Continues to Bear Fruit With New Scientific Article Showing MEAI Potential as a Novel Weight Loss Drug,20240806T125700,https://www.globenewswire.com/news-release/2024/08/06/2925081/0/en/SciSparc-s-Collaboration-with-Clearmind-Medicine-Continues-to-Bear-Fruit-With-New-Scientific-Article-Showing-MEAI-Potential-as-a-Novel-Weight-Loss-Drug.html,CMND,0.224903,Somewhat-Bullish,0.1773
Clearmind Medicine: New Scientific Publication Shows MEAI's Potential as a Novel Weight Loss Drug,20240806T125700,https://www.globenewswire.com/news-release/2024/08/06/2925083/0/en/Clearmind-Medicine-New-Scientific-Publication-Shows-MEAI-s-Potential-as-a-Novel-Weight-Loss-Drug.html,CMND,0.17715,Neutral,0.053143
Clearmind Medicine Concludes the Successful Participation in the Psychedelic Medicine - Israel 2024 Conference: Presented Industry Leaders its Groundbreaking Research,20240731T114400,https://www.globenewswire.com/news-release/2024/07/31/2921785/0/en/Clearmind-Medicine-Concludes-the-Successful-Participation-in-the-Psychedelic-Medicine-Israel-2024-Conference-Presented-Industry-Leaders-its-Groundbreaking-Research.html,CMND,0.152258,Somewhat-Bullish,0.267629
Clearmind Medicine Signs an Agreement to Source Manufacturers and Distributors for its Alcohol Substitute Beverage Product,20240719T115500,https://www.globenewswire.com/news-release/2024/07/19/2915832/0/en/Clearmind-Medicine-Signs-an-Agreement-to-Source-Manufacturers-and-Distributors-for-its-Alcohol-Substitute-Beverage-Product.html,CMND,0.190793,Somewhat-Bullish,0.2561
Nasdaq Edges Lower; Morgan Stanley Earnings Top Views - Morgan Stanley  ( NYSE:MS ) ,20240716T183151,https://www.benzinga.com/news/earnings/24/07/39802034/nasdaq-edges-lower-morgan-stanley-earnings-top-views,CMND,0.278222,Neutral,-0.148707
Crude Oil Down 1%; Bank of America Posts Upbeat Earnings - Bank of America  ( NYSE:BAC ) ,20240716T160052,https://www.benzinga.com/news/earnings/24/07/39799013/crude-oil-down-1-bank-of-america-posts-upbeat-earnings,CMND,0.276648,Neutral,-0.14803
Dow Jumps 400 Points; US Retail Sales Flat For June - Autonomix Medical  ( NASDAQ:AMIX ) ,20240716T140430,https://www.benzinga.com/news/earnings/24/07/39795907/dow-jumps-400-points-us-retail-sales-flat-for-june,CMND,0.331765,Somewhat-Bearish,-0.170847
Clearmind Medicine Obtains IND Approval from the FDA to Start the Phase I/IIa Clinical Trial with its Innovative Treatment for Alcoholism,20240716T130200,https://www.globenewswire.com/news-release/2024/07/16/2913847/0/en/Clearmind-Medicine-Obtains-IND-Approval-from-the-FDA-to-Start-the-Phase-I-IIa-Clinical-Trial-with-its-Innovative-Treatment-for-Alcoholism.html,CMND,0.429238,Somewhat-Bullish,0.233975
Clearmind Medicine Announces Submission of US Patent Application for Treating Metabolic Syndrome and Weight-loss,20240716T100300,https://www.globenewswire.com/news-release/2024/07/16/2913567/0/en/Clearmind-Medicine-Announces-Submission-of-US-Patent-Application-for-Treating-Metabolic-Syndrome-and-Weight-loss.html,CMND,0.13873,Neutral,0.116884
Clearmind Medicine to Present Groundbreaking Research at Psychedelic Medicine - Israel 2024 Conference,20240712T120200,https://www.globenewswire.com/news-release/2024/07/12/2912367/0/en/Clearmind-Medicine-to-Present-Groundbreaking-Research-at-Psychedelic-Medicine-Israel-2024-Conference.html,CMND,0.162255,Somewhat-Bullish,0.174089
Why Psychedelic-Pharma Clearmind Medicine Stock Is Moving Higher - Clearmind Medicine  ( NASDAQ:CMND ) ,20240628T171140,https://www.benzinga.com/news/24/06/39554543/why-psychedelic-pharma-clearmind-medicine-stock-is-moving-higher,CMND,0.461006,Bullish,0.402611
Clearmind Medicine Granted Patent Approval in Hong Kong for its Binge Behaviors Treatment,20240628T115500,https://www.globenewswire.com/news-release/2024/06/28/2905795/0/en/Clearmind-Medicine-Granted-Patent-Approval-in-Hong-Kong-for-its-Binge-Behaviors-Treatment.html,CMND,0.159569,Neutral,0.136675
Clearmind Medicine Granted Patent Approval in Hong Kong for its Binge Behaviors Treatment - Clearmind Medicine  ( NASDAQ:CMND ) ,20240628T115500,https://www.benzinga.com/pressreleases/24/06/g39546173/clearmind-medicine-granted-patent-approval-in-hong-kong-for-its-binge-behaviors-treatment,CMND,0.152178,Neutral,0.125712
Clearmind Medicine Secured Exclusive Global Rights to Innovative Psychedelic Compounds for PTSD Treatment,20240620T115700,https://www.globenewswire.com/news-release/2024/06/20/2901607/0/en/Clearmind-Medicine-Secured-Exclusive-Global-Rights-to-Innovative-Psychedelic-Compounds-for-PTSD-Treatment.html,CMND,0.140348,Neutral,0.134522
What's Going On With Clearmind Medicine Stock Tuesday? - Clearmind Medicine  ( NASDAQ:CMND ) ,20240611T163934,https://www.benzinga.com/news/24/06/39275472/whats-going-on-with-clearmind-medicine-stock-tuesday,CMND,0.313484,Neutral,0.139495
Clearmind Medicine Revolutionizes the $13 Billion NonAlcoholic Beverages Market with its Psychedelic-Based Drink,20240611T114400,https://www.globenewswire.com/news-release/2024/06/11/2896691/0/en/Clearmind-Medicine-Revolutionizes-the-13-Billion-NonAlcoholic-Beverages-Market-with-its-Psychedelic-Based-Drink.html,CMND,0.168884,Neutral,0.075751
Clearmind Medicine Revolutionizes the $13 Billion NonAlcoholic Beverages Market with its Psychedelic-Based Drink - Clearmind Medicine  ( NASDAQ:CMND ) ,20240611T114400,https://www.benzinga.com/pressreleases/24/06/g39267718/clearmind-medicine-revolutionizes-the-13-billion-nonalcoholic-beverages-market-with-its-psychedeli,CMND,0.159922,Neutral,0.067294
Clearmind Medicine Advances its Proprietary Psychedelic- Based Synthetic Alcohol Beverage Product,20240510T122400,https://www.globenewswire.com/news-release/2024/05/10/2879598/0/en/Clearmind-Medicine-Advances-its-Proprietary-Psychedelic-Based-Synthetic-Alcohol-Beverage-Product.html,CMND,0.142005,Neutral,0.067787
Clearmind Medicine Advances its Proprietary Psychedelic- Based Synthetic Alcohol Beverage Product - Clearmind Medicine  ( NASDAQ:CMND ) ,20240510T122400,https://www.benzinga.com/pressreleases/24/05/g38758890/clearmind-medicine-advances-its-proprietary-psychedelic-based-synthetic-alcohol-beverage-product,CMND,0.135602,Neutral,0.060877
Why Clearmind Medicine Stock Is Moving Higher - Clearmind Medicine  ( NASDAQ:CMND ) ,20240507T150321,https://www.benzinga.com/news/24/05/38673181/why-clearmind-medicine-stock-is-moving-higher,CMND,0.682689,Bullish,0.820927
Clearmind Medicine Secures Exclusive Global Rights to Breakthrough Psychedelic Compounds for PTSD Treatment,20240507T114600,https://www.globenewswire.com/news-release/2024/05/07/2876629/0/en/Clearmind-Medicine-Secures-Exclusive-Global-Rights-to-Breakthrough-Psychedelic-Compounds-for-PTSD-Treatment.html,CMND,0.122477,Neutral,0.126516
Clearmind Medicine Secures Exclusive Global Rights to Breakthrough Psychedelic Compounds for PTSD Treatment - Clearmind Medicine  ( NASDAQ:CMND ) ,20240507T114600,https://www.benzinga.com/pressreleases/24/05/g38665765/clearmind-medicine-secures-exclusive-global-rights-to-breakthrough-psychedelic-compounds-for-ptsd-,CMND,0.117486,Neutral,0.118108
Clearmind Applies to Cease Being a Reporting Issuer in Canada,20240430T201500,https://www.globenewswire.com/news-release/2024/04/30/2872793/0/en/Clearmind-Applies-to-Cease-Being-a-Reporting-Issuer-in-Canada.html,CMND,0.152821,Somewhat-Bullish,0.182148
Clearmind Medicine Announces Exclusive Licensing Agreement for Generation 3.0 Psychedelic Compounds for the Treatment of Mental Disorders,20240417T114900,https://www.globenewswire.com/news-release/2024/04/17/2864428/0/en/Clearmind-Medicine-Announces-Exclusive-Licensing-Agreement-for-Generation-3-0-Psychedelic-Compounds-for-the-Treatment-of-Mental-Disorders.html,CMND,0.140348,Neutral,0.136673
Clearmind Medicine Files U.S. Patent Application for Psychedelic-Based Treatment for Eating Disorders,20240410T111700,https://www.globenewswire.com/news-release/2024/04/10/2860639/0/en/Clearmind-Medicine-Files-U-S-Patent-Application-for-Psychedelic-Based-Treatment-for-Eating-Disorders.html,CMND,0.16317,Neutral,0.133783
Clearmind Medicine Files U.S. Patent Application for Psychedelic-Based Treatment for Eating Disorders - Clearmind Medicine  ( NASDAQ:CMND ) ,20240410T111700,https://www.benzinga.com/pressreleases/24/04/g38179532/clearmind-medicine-files-u-s-patent-application-for-psychedelic-based-treatment-for-eating-disorde,CMND,0.153145,Neutral,0.105304
Clearmind Medicine CEO Issues Letter to Shareholders,20240409T120700,https://www.globenewswire.com/news-release/2024/04/09/2859968/0/en/Clearmind-Medicine-CEO-Issues-Letter-to-Shareholders.html,CMND,0.294977,Somewhat-Bullish,0.18736
Clearmind Medicine Announces International Patent Application for Preventing and Treating Depression,20240327T131200,https://www.globenewswire.com/news-release/2024/03/27/2853253/0/en/Clearmind-Medicine-Announces-International-Patent-Application-for-Preventing-and-Treating-Depression.html,CMND,0.134841,Neutral,0.073645
SciSparc- Clearmind Collaboration Evolves with New International Patent Application for Preventing and Treating Depression,20240327T125500,https://www.globenewswire.com/news-release/2024/03/27/2853200/0/en/SciSparc-Clearmind-Collaboration-Evolves-with-New-International-Patent-Application-for-Preventing-and-Treating-Depression.html,CMND,0.20698,Neutral,0.083951
Breakthrough in Wellness: Clearmind Medicine's Psychedelic Treatment Granted Divisional Patent Approval in China,20240319T115500,https://www.globenewswire.com/news-release/2024/03/19/2848474/0/en/Breakthrough-in-Wellness-Clearmind-Medicine-s-Psychedelic-Treatment-Granted-Divisional-Patent-Approval-in-China.html,CMND,0.125898,Somewhat-Bullish,0.193994
Breakthrough in Wellness: Clearmind Medicine's Psychedelic Treatment Granted Divisional Patent Approval in China - Clearmind Medicine  ( NASDAQ:CMND ) ,20240319T115500,https://www.benzinga.com/pressreleases/24/03/g37818648/breakthrough-in-wellness-clearmind-medicines-psychedelic-treatment-granted-divisional-patent-appro,CMND,0.120834,Somewhat-Bullish,0.180836
Clearmind Medicine Obtains Clearance for its Psychedelic- Based Alcoholism Clinical Trial,20240313T121400,https://www.globenewswire.com/news-release/2024/03/13/2845404/0/en/Clearmind-Medicine-Obtains-Clearance-for-its-Psychedelic-Based-Alcoholism-Clinical-Trial.html,CMND,0.381172,Bullish,0.352593
Clearmind Medicine Received Approval for a Voluntary Delisting of its Common Shares From the Canadian Securities Exchange,20240313T113000,https://www.globenewswire.com/news-release/2024/03/13/2845324/0/en/Clearmind-Medicine-Received-Approval-for-a-Voluntary-Delisting-of-its-Common-Shares-From-the-Canadian-Securities-Exchange.html,CMND,0.211191,Somewhat-Bullish,0.22374
"Clearmind Medicine Submits Three Additional International Patent Applications for Innovative MDMA, Ibogaine and Ketamine Compounds - Clearmind Medicine  ( NASDAQ:CMND ) ",20240227T125800,https://www.benzinga.com/pressreleases/24/02/g37332889/clearmind-medicine-submits-three-additional-international-patent-applications-for-innovative-mdma-,CMND,0.098456,Neutral,0.075182
"SciSparc-Clearmind Partnership Yields Three New International Patent Applications for MDMA, Ibogaine and Ketamine Compounds - Clearmind Medicine  ( NASDAQ:CMND ) ",20240227T125800,https://www.benzinga.com/pressreleases/24/02/g37332890/scisparc-clearmind-partnership-yields-three-new-international-patent-applications-for-mdma-ibogain,CMND,0.217508,Neutral,0.083701
"Clearmind Medicine Submits Three Additional International Patent Applications for Innovative MDMA, Ibogaine and Ketamine Compounds",20240227T125800,https://www.globenewswire.com/news-release/2024/02/27/2835920/0/en/Clearmind-Medicine-Submits-Three-Additional-International-Patent-Applications-for-Innovative-MDMA-Ibogaine-and-Ketamine-Compounds.html,CMND,0.150278,Neutral,0.097932
"EXCLUSIVE: Psychedelic-Focused Firm Clearmind Medicine Submits Three New International Patent Applications For MDMA, Ibogaine And Ketamine Compounds - Clearmind Medicine  ( NASDAQ:CMND ) ",20240227T123037,https://www.benzinga.com/general/biotech/24/02/37332186/exclusive-psychedelic-focused-firm-clearmind-medicine-submits-three-new-international-patent-appl,CMND,0.524949,Neutral,0.022961
Clearmind Medicine Receives Approval to Commence its Phase I/IIa Clinical Trial of CMND-100 for Alcohol Use Disorder,20240223T120600,https://www.globenewswire.com/news-release/2024/02/23/2834392/0/en/Clearmind-Medicine-Receives-Approval-to-Commence-its-Phase-I-IIa-Clinical-Trial-of-CMND-100-for-Alcohol-Use-Disorder.html,CMND,0.380591,Bullish,0.377994
Next-Gen Psychedelics Companies SciSparc And Clearmind Collaboration File 3 Patents - Clearmind Medicine  ( NASDAQ:CMND ) ,20240221T161239,https://www.benzinga.com/markets/cannabis/24/02/37239879/next-gen-psychedelics-companies-scisparc-and-clearmind-collaboration-file-3-patents,CMND,0.259267,Neutral,0.0
What's Going On With Psychedelic Drug-Developers SciSparc And Clearmind Stock? - SciSparc  ( NASDAQ:SPRC ) ,20240220T182921,https://www.benzinga.com/markets/cannabis/24/02/37219436/whats-going-on-with-psychedelic-drug-developers-scisparc-and-clearmind-stock,CMND,0.219477,Somewhat-Bullish,0.226871
SciSparc and Clearmind Continue to Strengthen International Patent Portfolio with Next Generation Classic Psychedelic-Based Compounds,20240220T121400,https://www.globenewswire.com/news-release/2024/02/20/2831697/0/en/SciSparc-and-Clearmind-Continue-to-Strengthen-International-Patent-Portfolio-with-Next-Generation-Classic-Psychedelic-Based-Compounds.html,CMND,0.212425,Neutral,0.089054
Clearmind Medicine Submits Three International Patent Applications for Next Generation Classic Psychedelic-Based Compounds,20240220T121400,https://www.globenewswire.com/news-release/2024/02/20/2831696/0/en/Clearmind-Medicine-Submits-Three-International-Patent-Applications-for-Next-Generation-Classic-Psychedelic-Based-Compounds.html,CMND,0.147818,Neutral,0.096952
Clearmind Medicine Receives Patent Approval for its Psychedelic Based Treatment of Binge Behaviors in China,20240205T125100,https://www.globenewswire.com/news-release/2024/02/05/2823448/0/en/Clearmind-Medicine-Receives-Patent-Approval-for-its-Psychedelic-Based-Treatment-of-Binge-Behaviors-in-China.html,CMND,0.142284,Somewhat-Bullish,0.217665
"Clearmind Medicine Announces Exclusive, Long-Term Licensing Agreement with Leading Israeli Research Center - Clearmind Medicine  ( NASDAQ:CMND ) ",20240201T131500,https://www.benzinga.com/pressreleases/24/02/g36887068/clearmind-medicine-announces-exclusive-long-term-licensing-agreement-with-leading-israeli-research,CMND,0.072,Neutral,0.135486
"Clearmind Medicine Announces Exclusive, Long-Term Licensing Agreement with Leading Israeli Research Center",20240201T131500,https://www.globenewswire.com/news-release/2024/02/01/2821963/0/en/Clearmind-Medicine-Announces-Exclusive-Long-Term-Licensing-Agreement-with-Leading-Israeli-Research-Center.html,CMND,0.109622,Somewhat-Bullish,0.157695
"Psyched: Suggestibility And Psychedelics' Effects, EU's $7M Research Fund, Australia's Treatment Delivery, BZ Podcast And More - ATAI Life Sciences  ( NASDAQ:ATAI ) , Clearmind Medicine  ( NASDAQ:CMND ) ",20240127T150018,https://www.benzinga.com/markets/cannabis/24/01/36814962/psyched-suggestibility-and-psychedelics-effects-eus-7m-research-fund-australias-treatment-delive,CMND,0.09239,Neutral,0.0
Clearmind Medicine Inc. Closes US$2.4 Million Registered Direct and Private Placement - Clearmind Medicine  ( NASDAQ:CMND ) ,20240116T161934,https://www.benzinga.com/pressreleases/24/01/g36645025/clearmind-medicine-inc-closes-us-2-4-million-registered-direct-and-private-placement,CMND,0.112709,Neutral,0.093665
Clearmind Medicine Inc. Closes US$2.4 Million Registered Direct and Private Placement,20240116T161900,https://www.globenewswire.com/news-release/2024/01/16/2810139/0/en/Clearmind-Medicine-Inc-Closes-US-2-4-Million-Registered-Direct-and-Private-Placement.html,CMND,0.109123,Neutral,0.095949
"Psychedelics Headlines: MDMA & Coping Skills In PTSD, LSD's Perceived Risks, Knowledge Gaps, Surveys & More - ATAI Life Sciences  ( NASDAQ:ATAI ) , Clearmind Medicine  ( NASDAQ:CMND ) ",20240115T183832,https://www.benzinga.com/markets/cannabis/24/01/36623584/psychedelics-headlines-mdma-coping-skills-in-ptsd-lsds-perceived-risks-knowledge-gaps-surveys-mo,CMND,0.06211,Somewhat-Bearish,-0.207189
"Psyched: $100M For MDMA Therapy, VA Funds, 2024 Watchlist, Reform Updates And More - ATAI Life Sciences  ( NASDAQ:ATAI ) , Clearmind Medicine  ( NASDAQ:CMND ) ",20240112T215540,https://www.benzinga.com/markets/cannabis/24/01/36618728/psyched-100m-for-mdma-therapy-va-funds-2024-watchlist-reform-updates-and-more,CMND,0.095899,Neutral,-0.131577
"Crude Oil Moves Higher; Clearmind Medicine Shares Plummet - First Financial Northwest  ( NASDAQ:FFNW ) , Clearmind Medicine  ( NASDAQ:CMND ) ",20240111T193251,https://www.benzinga.com/news/earnings/24/01/36600288/crude-oil-moves-higher-clearmind-medicine-shares-plummet,CMND,0.217508,Somewhat-Bullish,0.189447
"Dow Dips Over 200 Points; First Financial Northwest Shares Spike Higher - First Financial Northwest  ( NASDAQ:FFNW ) , Clearmind Medicine  ( NASDAQ:CMND ) ",20240111T171136,https://www.benzinga.com/news/earnings/24/01/36598234/dow-dips-over-200-points-first-financial-northwest-shares-spike-higher,CMND,0.220809,Somewhat-Bullish,0.191674
Why Clearmind Medicine  ( CMND )  Shares Are Nosediving - Clearmind Medicine  ( NASDAQ:CMND ) ,20240111T154955,https://www.benzinga.com/news/24/01/36595516/why-clearmind-medicine-cmnd-shares-are-nosediving,CMND,0.693563,Somewhat-Bullish,0.152815
"US Stocks Higher; Inflation Rate Increases To 3.4% In December - 180 Life Sciences  ( NASDAQ:ATNF ) , Atreca  ( NASDAQ:BCEL ) ",20240111T144455,https://www.benzinga.com/news/earnings/24/01/36594814/us-stocks-higher-inflation-rate-increases-to-3-4-in-december,CMND,0.212425,Somewhat-Bullish,0.186022
Clearmind Medicine Inc. Announces Pricing of $2.4 Million Registered Direct and Private Placement,20240111T142800,https://www.globenewswire.com/news-release/2024/01/11/2808018/0/en/Clearmind-Medicine-Inc-Announces-Pricing-of-2-4-Million-Registered-Direct-and-Private-Placement.html,CMND,0.102158,Neutral,0.092626
"Why Richardson Electronics Shares Are Trading Lower By 13%; Here Are 20 Stocks Moving Premarket - 180 Life Sciences  ( NASDAQ:ATNF ) , Atreca  ( NASDAQ:BCEL ) ",20240111T125127,https://www.benzinga.com/news/24/01/36591851/why-richardson-electronics-shares-are-trading-lower-by-13-here-are-20-stocks-moving-premarket,CMND,0.208166,Neutral,-0.036487
"Crude Oil Falls 1%; Amarin Shares Spike Higher - Aehr Test Systems  ( NASDAQ:AEHR ) , Aclaris Therapeutics  ( NASDAQ:ACRS ) ",20240110T191625,https://www.benzinga.com/news/24/01/36582262/crude-oil-falls-1-amarin-shares-spike-higher,CMND,0.16117,Neutral,0.111389
"Nasdaq Gains 50 Points; US Crude Inventories Rise Last Week - Aehr Test Systems  ( NASDAQ:AEHR ) , Aclaris Therapeutics  ( NASDAQ:ACRS ) ",20240110T170400,https://www.benzinga.com/news/earnings/24/01/36580279/nasdaq-gains-50-points-us-crude-inventories-rise-last-week,CMND,0.162802,Neutral,0.112122
"Dow Surges 100 Points; PriceSmart Earnings Top Views - Aclaris Therapeutics  ( NASDAQ:ACRS ) , Clearmind Medicine  ( NASDAQ:CMND ) ",20240110T145056,https://www.benzinga.com/news/earnings/24/01/36577360/dow-surges-100-points-pricesmart-earnings-top-views,CMND,0.322023,Somewhat-Bearish,-0.156705
Clearmind Medicine Completed Type A Meeting with the FDA,20240110T121800,https://www.globenewswire.com/news-release/2024/01/10/2806995/0/en/Clearmind-Medicine-Completed-Type-A-Meeting-with-the-FDA.html,CMND,0.38588,Neutral,0.126014
"Psyched: Ibogaine For TBI, Kentucky Initiative Stalled, DEA Quotas, Insurance Codes, Atai's $50M And More - ATAI Life Sciences  ( NASDAQ:ATAI ) , Clearmind Medicine  ( NASDAQ:CMND ) ",20240107T173634,https://www.benzinga.com/general/biotech/24/01/36518391/psyched-ibogaine-for-tbi-kentucky-initiative-stalled-dea-quotas-insurance-codes-atais-50m-and-mor,CMND,0.104683,Neutral,-0.118564
SciSparc and Clearmind Medicine Reflect on Successful Collaboration in 2023 Aiming to Upgrade Wide Range of Psychedelic-Based Treatments,20240104T121800,https://www.globenewswire.com/news-release/2024/01/04/2803859/0/en/SciSparc-and-Clearmind-Medicine-Reflect-on-Successful-Collaboration-in-2023-Aiming-to-Upgrade-Wide-Range-of-Psychedelic-Based-Treatments.html,CMND,0.192183,Somewhat-Bullish,0.15009
Clearmind Medicine and SciSparc Reflect on Successful Collaboration in 2023 Aiming to Upgrade Wide Range of Psychedelic- Based Treatments,20240104T121800,https://www.globenewswire.com/news-release/2024/01/04/2803860/0/en/Clearmind-Medicine-and-SciSparc-Reflect-on-Successful-Collaboration-in-2023-Aiming-to-Upgrade-Wide-Range-of-Psychedelic-Based-Treatments.html,CMND,0.159305,Neutral,0.140202
"Psyched: Biden Approves Psychedelics Trials, RFK, Australia's First Legal Dedicated Clinic & More - Awakn Life Sciences  ( OTC:AWKNF ) , ATAI Life Sciences  ( NASDAQ:ATAI ) ",20231227T150926,https://www.benzinga.com/markets/cannabis/23/12/36390332/psyched-biden-approves-psychedelics-trials-rfk-australias-first-legal-dedicated-clinic-more,CMND,0.059194,Neutral,0.0
"Psyched: Biden's Big Decision On Psychedelics Therapy; LSD Anxiety Results; Matthew Perry Autopsy And More - Bright Minds Biosciences  ( NASDAQ:DRUG ) , Incannex Healthcare  ( NASDAQ:IXHL ) , Compass Pathways  ( NASDAQ:CMPS ) , GH Research  ( NASDAQ:GHRS ) ",20231218T172139,https://www.benzinga.com/markets/cannabis/23/12/36284691/psyched-bidens-big-decision-on-psychedelics-therapy-lsd-anxiety-results-matthew-perry-autopsy-an,CMND,0.079,Neutral,0.0
Clearmind Medicine Announces It Is In Compliance with All Applicable Nasdaq Listing Standards,20231214T132600,https://www.globenewswire.com/news-release/2023/12/14/2796248/0/en/Clearmind-Medicine-Announces-It-Is-In-Compliance-with-All-Applicable-Nasdaq-Listing-Standards.html,CMND,0.174587,Neutral,0.13796
"Why Johnson Controls International Shares Are Trading Lower By Over 6%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session - African Agriculture Hldgs  ( NASDAQ:AAGR ) , Achieve Life Sciences  ( NASDAQ:ACHV ) ",20231212T182222,https://www.benzinga.com/news/23/12/36203637/why-johnson-controls-international-shares-are-trading-lower-by-over-6-here-are-other-stocks-moving-i,CMND,0.147818,Somewhat-Bearish,-0.210557
"Why Icosavax Shares Are Trading Higher By Around 45%; Here Are 20 Stocks Moving Premarket - Assembly Biosciences  ( NASDAQ:ASMB ) , Achieve Life Sciences  ( NASDAQ:ACHV ) ",20231212T130008,https://www.benzinga.com/news/23/12/36194643/why-icosavax-shares-are-trading-higher-by-around-45-here-are-20-stocks-moving-premarket,CMND,0.232069,Somewhat-Bearish,-0.247013
"Psyched: John Lennon Remembered, Clinical Trials For Service Members, Chrissy Teigen, Jon Feliciano And More - ATAI Life Sciences  ( NASDAQ:ATAI ) , Braxia Scientific  ( OTC:BRAXF ) ",20231211T154327,https://www.benzinga.com/markets/cannabis/23/12/36167186/psyched-john-lennon-remembered-clinical-trials-for-service-members-chrissy-teigen-jon-feliciano-,CMND,0.087824,Neutral,-0.070057
"Crude Oil Moves Lower; AutoZone Profit Tops Views - AutoZone  ( NYSE:AZO ) , Clearmind Medicine  ( NASDAQ:CMND ) ",20231205T192749,https://www.benzinga.com/news/earnings/23/12/36099575/crude-oil-moves-lower-autozone-profit-tops-views,CMND,0.119235,Neutral,0.129998
"Dow Falls 100 Points; ISM Services PMI Increases In November - Allarity Therapeutics  ( NASDAQ:ALLR ) , Clearmind Medicine  ( NASDAQ:CMND ) ",20231205T171148,https://www.benzinga.com/news/earnings/23/12/36097189/dow-falls-100-points-ism-services-pmi-increases-in-november,CMND,0.126784,Neutral,0.133564
Why Clearmind Stock Is Climbing Higher Tuesday - Clearmind Medicine  ( NASDAQ:CMND ) ,20231205T152121,https://www.benzinga.com/news/23/12/36093387/why-clearmind-stock-is-climbing-higher-tuesday,CMND,0.720339,Bullish,0.541852
"Psyched: Defense Dept.'s Ketamine Trial, Cybin's Psilocybin, Metabolic Disorders, Reform Update And More - ATAI Life Sciences  ( NASDAQ:ATAI ) , Clearmind Medicine  ( NASDAQ:CMND ) ",20231205T151201,https://www.benzinga.com/markets/cannabis/23/12/36066535/psyched-defense-dept-s-ketamine-trial-cybins-psilocybin-metabolic-disorders-reform-update-and-mo,CMND,0.173958,Neutral,-0.094361
Clearmind Medicine Achieved Positive Results in Cocaine Addiction Treatment,20231205T134700,https://www.globenewswire.com/news-release/2023/12/05/2790952/0/en/Clearmind-Medicine-Achieved-Positive-Results-in-Cocaine-Addiction-Treatment.html,CMND,0.21686,Somewhat-Bullish,0.233006
"Why Salesforce Shares Are Trading Higher By Over 9%; Here Are 20 Stocks Moving Premarket - Aditxt  ( NASDAQ:ADTX ) , Ampio Pharmaceuticals  ( AMEX:AMPE ) ",20231130T130137,https://www.benzinga.com/news/23/11/36020980/why-salesforce-shares-are-trading-higher-by-over-9-here-are-20-stocks-moving-premarket,CMND,0.197413,Somewhat-Bearish,-0.262297
Why Clearmind Medicine Stock Is Moving Today - Clearmind Medicine  ( NASDAQ:CMND ) ,20231128T205518,https://www.benzinga.com/news/23/11/35988773/why-clearmind-medicine-stock-is-moving-today,CMND,0.514619,Neutral,0.099324
SciSparc Announces Positive Results from its Weight Loss and Metabolic Disorder Program with its Proprietary Psychedelic-Based Treatment,20231128T132500,https://www.globenewswire.com/news-release/2023/11/28/2786939/0/en/SciSparc-Announces-Positive-Results-from-its-Weight-Loss-and-Metabolic-Disorder-Program-with-its-Proprietary-Psychedelic-Based-Treatment.html,CMND,0.09347,Neutral,0.014233
Clearmind Medicine Announces Positive Results from its Weight Loss and Metabolic Disorder Program with its Proprietary Psychedelic- Based Treatment,20231128T132500,https://www.globenewswire.com/news-release/2023/11/28/2786940/0/en/Clearmind-Medicine-Announces-Positive-Results-from-its-Weight-Loss-and-Metabolic-Disorder-Program-with-its-Proprietary-Psychedelic-Based-Treatment.html,CMND,0.10863,Somewhat-Bullish,0.159727
"EXCLUSIVE: Clearmind Medicine's Psychedelic-Based Treatment Shows Encouraging Preclinical Activity In Obesity, Metabolic Disorders - Clearmind Medicine  ( NASDAQ:CMND ) ",20231128T130021,https://www.benzinga.com/general/biotech/23/11/35973403/exclusive-clearmind-medicines-psychedelic-based-treatment-shows-encouraging-preclinical-activity-,CMND,0.433523,Somewhat-Bullish,0.343661
Clearmind Medicine to Participate in Traditional vs. Novel Psychedelics Virtual Event with Leading Industry Figures,20231127T135500,https://www.globenewswire.com/news-release/2023/11/27/2786196/0/en/Clearmind-Medicine-to-Participate-in-Traditional-vs-Novel-Psychedelics-Virtual-Event-with-Leading-Industry-Figures.html,CMND,0.439026,Bullish,0.41805
"Why UP Fintech Shares Are Trading Higher By Around 7%; Here Are 20 Stocks Moving Premarket - AgriFORCE Growing Systems  ( NASDAQ:AGRI ) , Apollomics  ( NASDAQ:APLM ) ",20231127T131025,https://www.benzinga.com/news/23/11/35956771/why-up-fintech-shares-are-trading-higher-by-around-7-here-are-20-stocks-moving-premarket,CMND,0.216215,Neutral,-0.048479
Clearmind Medicine's Reverse Stock Split And Nasdaq Delisting Notice - Clearmind Medicine  ( NASDAQ:CMND ) ,20231121T192542,https://www.benzinga.com/markets/cannabis/23/11/35903164/clearmind-medicines-reverse-stock-split-and-nasdaq-delisting-notice,CMND,0.204072,Somewhat-Bullish,0.250848
Clearmind Medicine Announces 1-for-30 Reverse Share Split,20231121T131500,https://www.globenewswire.com/news-release/2023/11/21/2784036/0/en/Clearmind-Medicine-Announces-1-for-30-Reverse-Share-Split.html,CMND,0.151539,Neutral,0.111764
Clearmind Medicine Announces Receipt of Nasdaq Delisting Notice and Plan for Immediate Recompliance - Clearmind Medicine  ( NASDAQ:CMND ) ,20231117T211500,https://www.benzinga.com/pressreleases/23/11/g35857161/clearmind-medicine-announces-receipt-of-nasdaq-delisting-notice-and-plan-for-immediate-recomplianc,CMND,0.09402,Neutral,0.106071
Clearmind Medicine Announces Receipt of Nasdaq Delisting Notice and Plan for Immediate Recompliance,20231117T211500,https://www.globenewswire.com/news-release/2023/11/17/2782735/0/en/Clearmind-Medicine-Announces-Receipt-of-Nasdaq-Delisting-Notice-and-Plan-for-Immediate-Recompliance.html,CMND,0.143415,Neutral,0.143531
Clearmind Medicine Announces Shareholders Meeting Results,20231115T123700,https://www.globenewswire.com/news-release/2023/11/15/2780945/0/en/Clearmind-Medicine-Announces-Shareholders-Meeting-Results.html,CMND,0.362505,Somewhat-Bullish,0.340263
Clearmind Medicine to Pioneer Psychedelic Clinical Trials for Alcohol Use Disorder with Ivy League Universities,20231109T142000,https://www.globenewswire.com/news-release/2023/11/09/2777480/0/en/Clearmind-Medicine-to-Pioneer-Psychedelic-Clinical-Trials-for-Alcohol-Use-Disorder-with-Ivy-League-Universities.html,CMND,0.379291,Neutral,0.077072
Clearmind Medicine to Present at the 8th Annual Dawson James Conference on October 12th,20231005T130000,https://www.globenewswire.com/news-release/2023/10/05/2755423/0/en/Clearmind-Medicine-to-Present-at-the-8th-Annual-Dawson-James-Conference-on-October-12th.html,CMND,0.221819,Somewhat-Bullish,0.172198
Clearmind Medicine Closes US$2.25 Million Public Offering,20230918T161600,https://www.globenewswire.com/news-release/2023/09/18/2745083/0/en/Clearmind-Medicine-Closes-US-2-25-Million-Public-Offering.html,CMND,0.174272,Neutral,0.124636
"Psychedelics Capital Moves: Beckley Waves Raises $3.3M, Clearmind's $2.25M Public Offering - Clearmind Medicine  ( NASDAQ:CMND ) ",20230915T160918,https://www.benzinga.com/markets/cannabis/23/09/34595165/psychedelics-capital-moves-beckley-waves-raises-3-3m-clearminds-2-25m-public-offering,CMND,0.146025,Neutral,-0.093908
"Nasdaq Surges 100 Points; First Wave BioPharma Shares Spike Higher - Biolase  ( NASDAQ:BIOL ) , Clearmind Medicine  ( NASDAQ:CMND ) ",20230914T183007,https://www.benzinga.com/news/earnings/23/09/34591297/nasdaq-surges-100-points-first-wave-biopharma-shares-spike-higher,CMND,0.204647,Somewhat-Bullish,0.270794
"Crude Oil Rises Sharply; BIOLASE Shares Plunge - Biolase  ( NASDAQ:BIOL ) , Clearmind Medicine  ( NASDAQ:CMND ) ",20230914T161953,https://www.benzinga.com/news/earnings/23/09/34587190/crude-oil-rises-sharply-biolase-shares-plunge,CMND,0.206392,Somewhat-Bullish,0.272485
"Dow Jumps Over 200 Points; US Producer Prices Rise In August - Biolase  ( NASDAQ:BIOL ) , Clearmind Medicine  ( NASDAQ:CMND ) ",20230914T140356,https://www.benzinga.com/news/earnings/23/09/34582871/dow-jumps-over-200-points-us-producer-prices-rise-in-august,CMND,0.235062,Somewhat-Bullish,0.300254
"Why Novo Integrated Sciences Shares Are Trading Higher By 9%; Here Are 20 Stocks Moving Premarket - Avalo Therapeutics  ( NASDAQ:AVTX ) , Biolase  ( NASDAQ:BIOL ) ",20230914T120504,https://www.benzinga.com/news/23/09/34577092/why-novo-integrated-sciences-shares-are-trading-higher-by-9-here-are-20-stocks-moving-premarket,CMND,0.16849,Neutral,-0.0919
"Psyched: Psilocybin Therapy For Depression, UK Rescheduling, US Policy Reform And More - Awakn Life Sciences  ( OTC:AWKNF ) , ATAI Life Sciences  ( NASDAQ:ATAI ) ",20230911T133416,https://www.benzinga.com/markets/cannabis/23/09/34371541/psyched-psilocybin-therapy-for-depression-uk-rescheduling-us-policy-reform-and-more,CMND,0.088635,Neutral,0.122042
"Nasdaq Grants SpiSparc, Ltd. Extension To Maintain Listing: +600% Bid Price Surge Needed - SciSparc  ( NASDAQ:SPRC ) ",20230907T194536,https://www.benzinga.com/markets/cannabis/23/09/34332412/nasdaq-grants-spisparc-ltd-extension-to-maintain-listing-600-bid-price-surge-needed,CMND,0.143415,Neutral,-0.071708
Johns Hopkins Will Work With Clearmind On Alcohol Addiction Research Program - Clearmind Medicine  ( NASDAQ:CMND ) ,20230906T213636,https://www.benzinga.com/markets/cannabis/23/09/34292211/johns-hopkins-will-work-with-clearmind-on-alcohol-addiction-research-program,CMND,0.444919,Somewhat-Bullish,0.270928
Clearmind Medicine Announces Clinical Research Collaboration with Johns Hopkins University to Evaluate CMND-100 in Patients with Alcohol Use Disorder,20230906T132000,https://www.globenewswire.com/news-release/2023/09/06/2738525/0/en/Clearmind-Medicine-Announces-Clinical-Research-Collaboration-with-Johns-Hopkins-University-to-Evaluate-CMND-100-in-Patients-with-Alcohol-Use-Disorder.html,CMND,0.443626,Somewhat-Bullish,0.291394
"Clearmind Medicine Announces Collaboration with CTS Ltd., a Leading Pharmaceutical and Consumer Products Company",20230814T122500,https://www.globenewswire.com/news-release/2023/08/14/2724388/0/en/Clearmind-Medicine-Announces-Collaboration-with-CTS-Ltd-a-Leading-Pharmaceutical-and-Consumer-Products-Company.html,CMND,0.209365,Somewhat-Bullish,0.298865
"Clearmind Medicine Announces Collaboration with CTS Ltd., a Leading Pharmaceutical and Consumer Products Company - Clearmind Medicine  ( NASDAQ:CMND ) ",20230814T122500,https://www.benzinga.com/pressreleases/23/08/g33828771/clearmind-medicine-announces-collaboration-with-cts-ltd-a-leading-pharmaceutical-and-consumer-prod,CMND,0.154125,Somewhat-Bullish,0.227216
Clearmind Medicine Announces Share-Based Payment for the Company's Consultants,20230717T201500,https://www.globenewswire.com/news-release/2023/07/17/2705980/0/en/Clearmind-Medicine-Announces-Share-Based-Payment-for-the-Company-s-Consultants.html,CMND,0.202366,Somewhat-Bullish,0.187458
"Bright Minds Goes For 5:1 Shares Consolidation, Hopes To Regain NASDAQ Compliance - Bright Minds Biosciences  ( NASDAQ:DRUG ) ",20230711T192546,https://www.benzinga.com/markets/cannabis/23/07/33188838/bright-minds-goes-for-5-1-shares-consolidation-hopes-to-regain-nasdaq-compliance,CMND,0.141726,Neutral,-0.072276
3 Penny Stocks To Watch Right Now For Under $1,20230623T175721,https://pennystocks.com/featured/2023/06/23/3-penny-stocks-to-watch-right-now-for-under-1/,CMND,0.16171,Neutral,0.134883
SciSparc and Clearmind Medicine to Conduct a Study Evaluating Their Combination Treatment for Obesity and Metabolic Syndrome,20230616T130500,https://www.globenewswire.com/news-release/2023/06/16/2689752/0/en/SciSparc-and-Clearmind-Medicine-to-Conduct-a-Study-Evaluating-Their-Combination-Treatment-for-Obesity-and-Metabolic-Syndrome.html,CMND,0.137671,Neutral,0.083136
Clearmind Medicine and SciSparc to Conduct Study Evaluating Combination Treatment for Obesity and Metabolic Syndrome,20230616T130500,https://www.globenewswire.com/news-release/2023/06/16/2689751/0/en/Clearmind-Medicine-and-SciSparc-to-Conduct-Study-Evaluating-Combination-Treatment-for-Obesity-and-Metabolic-Syndrome.html,CMND,0.104228,Neutral,0.080286
"Exclusive: Clearmind And SciSparc To Conduct Study Evaluating Psychedelics And CannAmide Based Drug For Treatment Of Obesity And Metabolic Syndrome - SciSparc  ( NASDAQ:SPRC ) , Clearmind Medicine  ( NASDAQ:CMND ) ",20230616T124621,https://www.benzinga.com/markets/cannabis/23/06/32891785/exclusive-clearmind-and-scisparc-to-conduct-study-evaluating-psychedelics-and-cannamide-based-dr,CMND,0.254751,Neutral,0.054037
Clearmind Medicine to Host Virtual Investor Conference on Psychedelics for Obesity,20230609T133000,https://www.globenewswire.com/news-release/2023/06/09/2685574/0/en/Clearmind-Medicine-to-Host-Virtual-Investor-Conference-on-Psychedelics-for-Obesity.html,CMND,0.231884,Somewhat-Bullish,0.157806
"MEAI Compound's First Clinical Trial In US, Clearmind Enters NASDAQ Compliance Period - Clearmind Medicine  ( NASDAQ:CMND ) ",20230522T200301,https://www.benzinga.com/markets/cannabis/23/05/32513885/meai-compounds-first-clinical-trial-in-us-clearmind-enters-nasdaq-compliance-period,CMND,0.367141,Neutral,0.025732
Clearmind Medicine Announces Receipt of Nasdaq Minimum Bid Price Notification,20230519T201500,https://www.globenewswire.com/news-release/2023/05/19/2672789/0/en/Clearmind-Medicine-Announces-Receipt-of-Nasdaq-Minimum-Bid-Price-Notification.html,CMND,0.243376,Somewhat-Bullish,0.217834
"Why DXC Technology Shares Are Trading Lower By Around 5%; Here Are 20 Stocks Moving Premarket - Alimera Sciences  ( NASDAQ:ALIM ) , Clearmind Medicine  ( NASDAQ:CMND ) ",20230519T121734,https://www.benzinga.com/news/23/05/32483790/why-dxc-technology-shares-are-trading-lower-by-around-5-here-are-20-stocks-moving-premarket,CMND,0.285526,Neutral,0.057254
"Psyched: $20M Research Fund, LSD Microdosing For Cancer, MEAI Enters Clinical Stage, Reform Update & More - ATAI Life Sciences  ( NASDAQ:ATAI ) , Clearmind Medicine  ( NASDAQ:CMND ) ",20230515T213048,https://www.benzinga.com/markets/cannabis/23/05/32404420/psyched-20m-research-fund-lsd-microdosing-for-cancer-meai-enters-clinical-stage-reform-update-mo,CMND,0.141171,Neutral,-0.050598
Best Penny Stocks To Buy Now? 7 Under $1 To Watch,20230512T151640,https://pennystocks.com/featured/2023/05/12/best-penny-stocks-to-buy-now-7-under-1-to-watch-may-2023/,CMND,0.17689,Neutral,0.141881
Clearmind Medicine Announces IRB Approval to Conduct Clinical Trial on Alcohol Use Disorder,20230512T130000,https://www.globenewswire.com/news-release/2023/05/12/2667849/0/en/Clearmind-Medicine-Announces-IRB-Approval-to-Conduct-Clinical-Trial-on-Alcohol-Use-Disorder.html,CMND,0.514619,Somewhat-Bullish,0.241376
EXCLUSIVE: Clearmind Medicine Secures Approval To Launch Clinical Trial For Alcohol Addiction Treatment - Clearmind Medicine  ( NASDAQ:CMND ) ,20230512T123007,https://www.benzinga.com/markets/cannabis/23/05/32355169/exclusive-clearmind-medicine-secures-approval-to-launch-clinical-trial-for-alcohol-addiction-tre,CMND,0.574748,Bullish,0.354691
"Psyched: Psychedelics Reimbursement, Amanita Muscaria Boom, $53M Material Breach Lawsuit & More - Compass Pathways  ( NASDAQ:CMPS ) , Clearmind Medicine  ( NASDAQ:CMND ) ",20230508T202323,https://www.benzinga.com/markets/cannabis/23/05/32270868/psyched-psychedelics-reimbursement-amanita-muscaria-boom-53m-material-breach-lawsuit-more,CMND,0.113329,Neutral,0.0
Next-Gen Israeli Psychedelics Company Gears Up For Trial Targeting Alcohol Addiction - Clearmind Medicine  ( NASDAQ:CMND ) ,20230503T190425,https://www.benzinga.com/markets/cannabis/23/05/32193519/next-gen-israeli-psychedelics-company-gears-up-for-trial-targeting-alcohol-addiction,CMND,0.551295,Somewhat-Bullish,0.245016
"Why Meta Platforms Shares Are Trading Higher By Over 11%; Here Are 20 Stocks Moving Premarket - American Rebel Holdings  ( NASDAQ:AREB ) , Atomera  ( NASDAQ:ATOM ) ",20230427T114104,https://www.benzinga.com/news/23/04/32043114/why-meta-platforms-shares-are-trading-higher-by-over-11-here-are-20-stocks-moving-premarket,CMND,0.139669,Neutral,-0.125529
Why Chipotle Shares Are Trading Higher By 13%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session,20230426T181251,https://markets.businessinsider.com/news/stocks/why-chipotle-shares-are-trading-higher-by-13-here-are-other-stocks-moving-in-wednesday-s-mid-day-session-1032264876,CMND,0.032338,Neutral,0.063674
"SciSparc And Clearmind Collaboration Strengthens IP Portfolio With Patent Application For Treatment Of Depression - SciSparc  ( NASDAQ:SPRC ) , Clearmind Medicine  ( NASDAQ:CMND ) ",20230421T131206,https://www.benzinga.com/markets/cannabis/23/04/31934517/scisparc-and-clearmind-collaboration-strengthens-ip-portfolio-with-patent-application-for-treatm,CMND,0.423843,Somewhat-Bullish,0.259757
Clearmind Medicine Expanding IP Portfolio with New US Patent Application for Treatment of Depression,20230421T123000,https://www.globenewswire.com/news-release/2023/04/21/2651925/0/en/Clearmind-Medicine-Expanding-IP-Portfolio-with-New-US-Patent-Application-for-Treatment-of-Depression.html,CMND,0.183895,Neutral,0.104843
"Psyched Clinical Trials: Australian Univ. Pursues MDMA, MEAI Compound About To Set Off - Clearmind Medicine  ( NASDAQ:CMND ) ",20230420T184804,https://www.benzinga.com/markets/cannabis/23/04/31920294/psyched-clinical-trials-australian-univ-pursues-mdma-meai-compound-about-to-set-off,CMND,0.236588,Neutral,0.092745
Clearmind Medicine Engages Experienced Contract Research Organization to Support its First-in-Human Clinical Trial,20230420T093700,https://www.globenewswire.com/news-release/2023/04/20/2650754/0/en/Clearmind-Medicine-Engages-Experienced-Contract-Research-Organization-to-Support-its-First-in-Human-Clinical-Trial.html,CMND,0.337811,Somewhat-Bullish,0.189614
"Why Sonnet BioTherapeutics Shares Are Trading Lower By Around 13%; Here Are 20 Stocks Moving Premarket - a.k.a. Brands Holding  ( NYSE:AKA ) , Bed Bath & Beyond  ( NASDAQ:BBBY ) ",20230419T121333,https://www.benzinga.com/news/23/04/31888196/why-sonnet-biotherapeutics-shares-are-trading-lower-by-around-13-here-are-20-stocks-moving-premarket,CMND,0.172919,Neutral,0.108397
"Why iMedia Brands Shares Are Trading Higher By Over 13%; Here Are 20 Stocks Moving Premarket - IMAC Hldgs  ( NASDAQ:BACK ) , Brenmiller Energy  ( NASDAQ:BNRG ) ",20230412T122758,https://www.benzinga.com/news/23/04/31766625/why-imedia-brands-shares-are-trading-higher-by-over-13-here-are-20-stocks-moving-premarket,CMND,0.220809,Somewhat-Bullish,0.211672
"Why National CineMedia Shares Are Trading Higher By Around 111%; Here Are 20 Stocks Moving Premarket - Agrify  ( NASDAQ:AGFY ) , Brenmiller Energy  ( NASDAQ:BNRG ) ",20230411T122012,https://www.benzinga.com/news/23/04/31741625/why-national-cinemedia-shares-are-trading-higher-by-around-111-here-are-20-stocks-moving-premarket,CMND,0.163354,Somewhat-Bullish,0.198317
Clearmind Medicine Closes US$3.5 Million Public Offering,20230406T201500,https://www.globenewswire.com/news-release/2023/04/06/2642995/0/en/Clearmind-Medicine-Closes-US-3-5-Million-Public-Offering.html,CMND,0.176502,Neutral,0.127296
"How To Finance A Psychedelics Business? Learn From These Four Companies - Algernon Pharmaceuticals  ( OTC:AGNPF ) , Clearmind Medicine  ( NASDAQ:CMND ) ",20230404T204142,https://www.benzinga.com/markets/cannabis/23/04/31666193/how-to-finance-a-psychedelics-business-learn-from-these-four-companies,CMND,0.143415,Neutral,-0.030651
"Dow Tumbles Over 200 Points; Butterfly Network Shares Spike Higher - Bullfrog AI Hldgs  ( NASDAQ:BFRG ) , Butterfly Network  ( NYSE:BFLY ) ",20230404T183314,https://www.benzinga.com/news/earnings/23/04/31664410/dow-tumbles-over-200-points-butterfly-network-shares-spike-higher,CMND,0.205225,Neutral,0.138564
"Gold Rises Sharply; AMC Entertainment Shares Plunge - AeroVironment  ( NASDAQ:AVAV ) , AMC Enter Hldgs  ( NYSE:AMC ) ",20230404T160858,https://www.benzinga.com/news/earnings/23/04/31661623/gold-rises-sharply-amc-entertainment-shares-plunge,CMND,0.197413,Neutral,0.134541
Why Clearmind Medicine Shares Are Nosediving - Clearmind Medicine  ( NASDAQ:CMND ) ,20230404T155253,https://www.benzinga.com/news/23/04/31660149/why-clearmind-medicine-shares-are-nosediving,CMND,0.895116,Somewhat-Bullish,0.190444
"Psyched: 22 States With Reform Bills, Ketamine Therapy Services Today, Oscars On Shrooms & More - Filament Health  ( OTC:FLHLF ) , AdvisorShares Psychedelics ETF  ( ARCA:PSIL ) , Field Trip Health  ( OTC:FTHWF ) , FSD Pharma  ( NASDAQ:HUGE ) , Reunion Neuroscience  ( NASDAQ:REUN ) , Lucy Scientific Discovery  ( NASDAQ:LSDI ) , Delic Hldgs  ( OTC:DELCF ) , ETF Series Solutions PSYK ETF  ( ARCA:PSYK ) , Incannex Healthcare  ( NASDAQ:IXHL ) , Red Light Holland  ( OTC:TRUFF ) , Compass Pathways  ( NASDAQ:CMPS ) , Enveric Biosciences  ( NASDAQ:ENVB ) , Braxia Scientific  ( OTC:BRAXF ) , Mindset Pharma  ( OTC:MSSTF ) , Irwin Naturals  ( OTC:IWINF ) , Clearmind Medicine  ( NASDAQ:CMND ) , SILO Pharma  ( NASDAQ:SILO ) ",20230320T211105,https://www.benzinga.com/markets/cannabis/23/03/31428098/psyched-22-states-with-reform-bills-ketamine-therapy-services-today-oscars-on-shrooms-more,CMND,0.082393,Somewhat-Bearish,-0.18016
A Drug That Mimics Alcohol Buzz Is Bound For Human Trials: Here's What's Next - Clearmind Medicine  ( NASDAQ:CMND ) ,20230317T153021,https://www.benzinga.com/markets/cannabis/23/03/31386157/a-drug-that-mimics-alcohol-buzz-is-bound-for-human-trials-heres-whats-next,CMND,0.544495,Bullish,0.406097
"Clearmind Medicine Appoints Professor Henry R. Kranzler, M.D., to Scientific Advisory Board",20230314T125500,https://www.globenewswire.com/news-release/2023/03/14/2626683/0/en/Clearmind-Medicine-Appoints-Professor-Henry-R-Kranzler-M-D-to-Scientific-Advisory-Board.html,CMND,0.187827,Neutral,0.131178
"US Stocks Mostly Higher; Dow Rises 75 Points - Bluegreen Vacations  ( NYSE:BVH ) , Calliditas Therapeutics  ( NASDAQ:CALT ) ",20230313T141541,https://www.benzinga.com/news/earnings/23/03/31321718/us-stocks-mostly-higher-dow-rises-75-points,CMND,0.146025,Bullish,0.438021
"SciSparc And Clearmind Reveal Three Unique Combinations Of Future Psychedelic-Based Compounds - SciSparc  ( NASDAQ:SPRC ) , Clearmind Medicine  ( NASDAQ:CMND ) ",20230222T160646,https://www.benzinga.com/markets/cannabis/23/02/31010075/scisparc-and-clearmind-reveal-three-unique-combinations-of-future-psychedelic-based-compounds,CMND,0.366061,Somewhat-Bullish,0.214588
"Novel Combination Of Cannabis-Like Compound With Classical Psychedelics Searches IP Coverage In US - SciSparc  ( NASDAQ:SPRC ) , Clearmind Medicine  ( NASDAQ:CMND ) ",20230215T174708,https://www.benzinga.com/markets/cannabis/23/02/30929361/novel-combination-of-cannabis-like-compound-with-classical-psychedelics-searches-ip-coverage-in-,CMND,0.188193,Neutral,0.125523
"EXCLUSIVE: Next-Generation Psychedelics, MEAI - The Road Ahead",20230201T155133,https://www.benzinga.com/markets/cannabis/23/02/30647634/exclusive-next-generation-psychedelics-meai-the-road-ahead,CMND,0.101582,Neutral,0.0
Israeli Biotech Develops Ketamine Analogue To Treat Major Depression With Promising Results,20230131T165857,https://www.benzinga.com/markets/cannabis/23/01/30647483/israeli-biotech-develops-ketamine-analogue-to-treat-major-depression-with-promising-results,CMND,0.224903,Neutral,-0.081851
"Psyched: States With Psychedelics Legalization Bills, Next-Gen Molecule For Addiction Treatment And More",20230125T170257,https://www.benzinga.com/markets/cannabis/23/01/30548708/psyched-states-with-psychedelics-legalization-bills-next-gen-molecule-for-addiction-treatment-an,CMND,0.082677,Neutral,0.057107
"EXCLUSIVE: Next-Generation Psychedelics, MEAI - What And When",20230124T203246,https://www.benzinga.com/markets/cannabis/23/01/30531250/exclusive-next-generation-psychedelics-meai-what-and-when,CMND,0.170878,Neutral,-0.028781
"EXCLUSIVE: Next-Generation Psychedelics, MEAI - How And Why, An Israeli Scientist Explains",20230123T162750,https://www.benzinga.com/markets/cannabis/23/01/30508635/exclusive-next-generation-psychedelics-meai-how-and-why-an-israeli-scientist-explains,CMND,0.115232,Neutral,0.074481
Next-Generation Psychedelics: The Case Of MEAI And Its Potential To Treat Addiction,20230120T142953,https://www.benzinga.com/markets/cannabis/23/01/30484920/next-generation-psychedelics-the-case-of-meai-and-its-potential-to-treat-addiction,CMND,0.170878,Neutral,0.07847
"Clearmind Teams With Yissum, University of Jerusalem On 2 Psychedelic R&D Projects",20230119T195703,https://www.benzinga.com/markets/cannabis/23/01/30490764/clearmind-teams-with-yissum-university-of-jerusalem-on-2-psychedelic-r-d-projects,CMND,0.244109,Bullish,0.394452
Envisioning A Cocaine-Addiction Treatment: This Next-Gen Psychedelic Shows Positive Results,20230118T171922,https://www.benzinga.com/markets/cannabis/23/01/30462564/envisioning-a-cocaine-addiction-treatment-this-next-gen-psychedelic-shows-positive-results,CMND,0.185306,Bullish,0.466704
5 Penny Stocks To Watch After Big News This Week,20230117T142414,https://pennystocks.com/featured/2023/01/17/5-penny-stocks-to-watch-after-big-news-this-week-january-17/,CMND,0.038717,Neutral,0.11914
Israel-Based Clearmind Medicine Successfully Completes Production of CMND-100 Drug Candidate for Clinical Trial,20230110T133000,https://www.globenewswire.com/news-release/2023/01/10/2586168/0/en/Israel-Based-Clearmind-Medicine-Successfully-Completes-Production-of-CMND-100-Drug-Candidate-for-Clinical-Trial.html,CMND,0.34729,Somewhat-Bullish,0.271842
"This Original Psychedelic-Based Obesity Treatment Set To First-In-Human Trials - SciSparc  ( NASDAQ:SPRC ) , Clearmind Medicine  ( NASDAQ:CMND ) ",20230106T184507,https://www.benzinga.com/markets/cannabis/23/01/30298760/this-original-psychedelic-based-obesity-treatment-set-to-first-in-human-trials,CMND,0.130571,Somewhat-Bullish,0.256425
Clearmind Medicine Announces Shareholders Meeting Results,20221229T110000,https://www.globenewswire.com/news-release/2022/12/29/2580543/0/en/Clearmind-Medicine-Announces-Shareholders-Meeting-Results.html,CMND,0.414559,Bullish,0.430141
Israel-Based Clearmind Medicine Announces First Clinical Center to Join Its Clinical Trial for Alcohol Use Disorder,20221228T140000,https://www.globenewswire.com/news-release/2022/12/28/2580269/0/en/Israel-Based-Clearmind-Medicine-Announces-First-Clinical-Center-to-Join-Its-Clinical-Trial-for-Alcohol-Use-Disorder.html,CMND,0.235823,Neutral,0.096832
"Israeli Psychedelics Biotech Shares Latest Advancements, Moves Forward With Addictions Treatment - Clearmind Medicine  ( NASDAQ:CMND ) ",20221219T152824,https://www.benzinga.com/markets/cannabis/22/12/30110616/israeli-psychedelics-biotech-shares-latest-advancements-moves-forward-with-addictions-treatment,CMND,0.457977,Neutral,0.093095
"Dow Tumbles Over 500 Points; ECB Raises Rates By 50 bps - Azure Power Global  ( NYSE:AZRE ) , Genie Energy  ( NYSE:GNE ) ",20221215T150950,https://www.benzinga.com/news/earnings/22/12/30093755/dow-tumbles-over-500-points-ecb-raises-rates-by-50-bps,CMND,0.114682,Neutral,0.115672
Israeli Biotech Clearmind Medicine Appoints ex-Red Bull Executive Special Advisor for Developing MEAI as Alcohol Substitute,20221209T140200,https://www.globenewswire.com/news-release/2022/12/09/2571107/0/en/Israeli-Biotech-Clearmind-Medicine-Appoints-ex-Red-Bull-Executive-Special-Advisor-for-Developing-MEAI-as-Alcohol-Substitute.html,CMND,0.312158,Somewhat-Bullish,0.235847
Clearmind Gears Up For Clinical Trial To Test Drug That Treats Alcohol Addiction - Clearmind Medicine Inc. - Common Shares  ( NASDAQ:CMND ) ,20221123T202214,https://www.benzinga.com/markets/cannabis/22/11/29842354/clearmind-gears-up-for-clinical-trial-to-test-drug-that-treats-alcohol-addiction,CMND,0.412861,Somewhat-Bullish,0.26961
"Cannabis Deal Tracker: Investment and M&A Activity in the Cannabis Industry November 14th, 2022 - November 18th, 2022",20221123T190700,https://www.investorideas.com/news/2022/cannabis/11231DealTracker.asp,CMND,0.074001,Neutral,0.138285
Clearmind Announces Initiation of CMND-100 Manufacturing Program to Address its Upcoming Clinical Trial,20221123T134500,https://www.globenewswire.com/news-release/2022/11/23/2561628/0/en/Clearmind-Announces-Initiation-of-CMND-100-Manufacturing-Program-to-Address-its-Upcoming-Clinical-Trial.html,CMND,0.380736,Neutral,0.134509
Clearmind Announces Initiation of CMND-100 Manufacturing Program to Address its Upcoming Clinical Trial - Clearmind Medicine Inc. - Common Shares  ( NASDAQ:CMND ) ,20221123T134500,https://www.benzinga.com/pressreleases/22/11/g29838706/clearmind-announces-initiation-of-cmnd-100-manufacturing-program-to-address-its-upcoming-clinical-,CMND,0.379291,Neutral,0.123445
